000 01167 a2200373 4500
005 20250514063009.0
264 0 _c20030514
008 200305s 0 0 eng d
022 _a0006-3525
024 7 _a10.1002/bip.10349
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPaganelli, G
245 0 0 _a90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies.
_h[electronic resource]
260 _bBiopolymers
_c2002
300 _a393-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aHumans
650 0 4 _aNeuroendocrine Tumors
_xdrug therapy
650 0 4 _aOctreotide
_xadverse effects
650 0 4 _aRadiopharmaceuticals
_xadverse effects
650 0 4 _aSomatostatin
_xanalogs & derivatives
700 1 _aBodei, L
700 1 _aHandkiewicz Junak, D
700 1 _aRocca, P
700 1 _aPapi, S
700 1 _aLopera Sierra, M
700 1 _aGatti, M
700 1 _aChinol, M
700 1 _aBartolomei, M
700 1 _aFiorenza, M
700 1 _aGrana, C
773 0 _tBiopolymers
_gvol. 66
_gno. 6
_gp. 393-8
856 4 0 _uhttps://doi.org/10.1002/bip.10349
_zAvailable from publisher's website
999 _c12452277
_d12452277